Skip to Content
Merck
  • Skeletal muscle ceramides and relationship with insulin sensitivity after 2 weeks of simulated sedentary behaviour and recovery in healthy older adults.

Skeletal muscle ceramides and relationship with insulin sensitivity after 2 weeks of simulated sedentary behaviour and recovery in healthy older adults.

The Journal of physiology (2018-09-09)
Paul T Reidy, Alec I McKenzie, Ziad Mahmassani, Vincent R Morrow, Nikol M Yonemura, Paul N Hopkins, Robin L Marcus, Matthew T Rondina, Yu Kuei Lin, Micah J Drummond
ABSTRACT

Insulin sensitivity (as determined by a hyperinsulinaemic-euglyceamic clamp) decreased 15% after reduced activity. Despite not fully returning to baseline physical activity levels, insulin sensitivity unexpectedly, rebounded above that recorded before 2 weeks of reduced physical activity by 14% after the recovery period. Changes in insulin sensitivity in response to reduced activity were primarily driven by men but, not women. There were modest changes in ceramides (nuclear/myofibrillar fraction and serum) following reduced activity and recovery but, in the absence of major changes to body composition (i.e. fat mass), ceramides were not related to changes in inactivity-induced insulin sensitivity in healthy older adults. Older adults are at risk of physical inactivity as they encounter debilitating life events. It is not known how insulin sensitivity is affected by modest short-term physical inactivity and recovery in healthy older adults, nor how insulin sensitivity is related to changes in serum and muscle ceramide content. Healthy older adults (aged 64-82 years, five females, seven males) were assessed before (PRE), after 2 weeks of reduced physical activity (RA) and following 2 weeks of recovery (REC). Insulin sensitivity (hyperinsulinaemic-euglyceamic clamp), lean mass, muscle function, skeletal muscle subfraction, fibre-specific, and serum ceramide content and indices of skeletal muscle inflammation were assessed. Insulin sensitivity decreased by 15 ± 6% at RA (driven by men) but rebounded above PRE by 14 ± 5% at REC. Mid-plantar flexor muscle area and leg strength decreased with RA, although only muscle size returned to baseline levels following REC. Body fat did not change and only minimal changes in muscle inflammation were noted across the intervention. Serum and intramuscular ceramides (nuclear/myofibrillar fraction) were modestly increased at RA and REC. However, ceramides were not related to changes in inactivity-induced insulin sensitivity in healthy older adults. Short-term inactivity induced insulin resistance in older adults in the absence of significant changes in body composition (i.e. fat mass) are not related to changes in ceramides.

MATERIALS
Product Number
Brand
Product Description

Avanti
15:0-18:1-d7 DG, Avanti Research - A Croda Brand 791647C
Avanti
C16 Ceramide-d7 (d18:1-d7/16:0), Avanti Research - A Croda Brand 860676P, powder
Avanti
C24:1 Ceramide-d7 (d18:1-d7/24:1(15Z)), Avanti Research - A Croda Brand 860679P, powder
Avanti
C24 Ceramide-d7 (d18:1-d7/24:0), Avanti Research - A Croda Brand 860678P, powder
Avanti
C18 Ceramide-d7 (d18:1-d7/18:0), Avanti Research - A Croda Brand 860677P, powder
Avanti
17:0 SM (d18:1/17:0), Avanti Research - A Croda Brand 860585P, powder
Avanti
C18:1 Dihydroceramide (d18:0/18:1(9Z)), Avanti Research - A Croda Brand 860624P, powder